Free interactive webinar on closed-loop systems

Diabetes-Knowledge In Practice Logo

On May 16 at 17:00 BST, Professor David Matthews will host an interactive discussion of Laurel Messer’s recent paper on closed-loop insulin pumps. Entitled ‘Exploring closed-loop therapy’, their webinar will provide an unmissable opportunity to discuss novel data with international experts.

Closed-loop systems are an advanced form of insulin pump that combine continuous glucose monitoring with continuous subcutaneous insulin infusion. These closed-loops continuously monitor blood glucose concentrations and alter the rate of insulin delivered by a transdermal pump: if blood glucose begins to rise, the device will increase the amount of insulin provided, helping to maintain a constant, healthy blood glucose level.

Although closed-loop systems are not yet available in Europe, one similar device has been approved in America. A recent study of this hybrid closed-loop system has revealed key insights into the real-world use of such a device in adolescents and young adults, including its impact on glucose control. Following 31 patients for three months, the study found that use of closed-loop insulin delivery was associated with a 14% increase in time spent at a healthy blood glucose level and an HbA1c reduction of 0.75%.

So what does this mean for your patients? And what impact can we expect to see once closed-loop systems become available in Europe?

To find out, join our webinar on May 16. Registration is free and takes under 30 seconds.

If you regularly see patients with type 1 diabetes, don’t miss this exciting opportunity to have your questions answered by Professor David Matthews and Laurel Messer, both international experts in this area.

Register your interest today

This interactive session will be run by Diabetes Knowledge in Practice. This educational programme features a range of free, CME-accredited e-learning modules designed by leading experts in diabetes management. Topics include navigating insulin choices, managing diabetes in pregnancy, effective use of GLP-1 receptor agonists and helping patients address post-prandial glucose concentrations.

Diabetes Knowledge in Practice is supported by an educational grant from Novo Nordisk. The educational content has been developed by Liberum IME and validated by an independent steering committee; Novo Nordisk has had no influence on the content of this education.

Posted in